VC  Logos Capital

https://www.logoscapital.com/





     Office Locations:

1 Letterman Drive, Building C, Suite C3-350
San Francisco, CA 94129
Phone: 415-801-4660

 
Stages:

  • Early


 
Industries:

  • Life Sciences & Healthcare

  •  
    Description:

    Logos Capital is dedicated to advancing healthcare through disciplined, data-driven investment in biotechnology. Logos Capital is led by a team of experts from diverse scientific and financial backgrounds, including chemistry, engineering, biology, and data science.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     
    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Arsani William Managing Partner
    Graham Walmsley Managing Partner

     
    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      03/26/2026


      Pinnacle Medicines


      PA


      $89,000,000


      Series B


      02/12/2026


      Alva Energy


      MA


      $33,000,000


      Series A


      01/22/2026


      Mia Labs


      TX


      $20,000,000


      Series A


      01/12/2026


      Diagonal Therapeutics


      MA


      $125,000,000


      Series B


      10/09/2025


      Expedition Therapeutics


      CA


      $165,000,000


      Series A


     
    Portfolio companies include:

     
    Recent News: